Item 5. Other Information
3K characters. Original on sec.gov ·
Item 5. Other Information
(c) Trading Plans
No director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K) during the three months ended September 30, 2025, except as follows:
| Name | Title | Action | Date of adoption/termination | Scheduled expiration date****1 | Aggregate number of securities to be purchased/sold | |||||||||||||||||||||||||||
| Ravi Kumar S | Chief Executive Officer | Adoption | August 15, 2025 | November 13, 2026 | Sale of up to 11,630 shares of common stock | |||||||||||||||||||||||||||
| Alina Kerdman | Senior Vice President, Controller and Chief Accounting Officer | Adoption | August 19, 2025 | December 31, 2026 | (2) | |||||||||||||||||||||||||||
| Surya Gummadi | President-Americas | Adoption | August 27, 2025 | August 19, 2026 | Sale of up to 22,728 shares of common stock | |||||||||||||||||||||||||||
| Michael Patsalos-Fox | Director | Termination | September 10, 2025 | February 20, 2026 | Sale of up to 25,000 shares of common stock | |||||||||||||||||||||||||||
| Michael Patsalos-Fox | Director | Adoption | September 11, 2025 | September 11, 2026 | Sale of up to 25,000 shares of common stock | |||||||||||||||||||||||||||
| John Kim | Chief Legal Officer, Chief Administrative Officer and Corporate Secretary | Adoption | September 12, 2025 | May 29, 2026 | Sale of up to 10,000 shares of common stock |
(1) The trading plan may also expire on such earlier date as all transactions under the trading plan are completed.
(2) The trading plan permits the sale of up to the net shares of common stock to be issued to Ms. Kerdman after the satisfaction of applicable taxes following the vesting and settlement of 3,641 RSUs.
Each of the trading arrangements listed in the above table is intended to satisfy the affirmative defense conditions of Rule 10b5-1.
| Cognizant Technology Solutions | 42 | September 30, 2025 Form 10-Q |
Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits